George Kemble - Jul 19, 2024 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Executive Chairman, Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Stock symbol
SGMT
Transactions as of
Jul 19, 2024
Transactions value $
-$43,605
Form type
4
Date filed
7/23/2024, 04:05 PM
Previous filing
Nov 21, 2023
Next filing
Jul 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGMT Series A Common Stock Sale -$43.6K -14.1K -8.99% $3.10 142K Jul 19, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.